New diabetes clinical trial: Repurposing Colchicine for Reduction of Residual Inflammatory Risk in Type 1 Diabetes
Published on: July 18, 2023 at 11:00AM
Conditions: Type 1 Diabetes; Cardiovascular Diseases; Chronic Inflammation
Interventions: Drug: Colchicine 0.5 MG Oral Tablet; Drug: Placebo
Sponsors: Filip Krag Knop; University of Copenhagen; Juvenile Diabetes Research Foundation
Not yet recruiting
https://ift.tt/8MXpiSE
Conditions: Type 1 Diabetes; Cardiovascular Diseases; Chronic Inflammation
Interventions: Drug: Colchicine 0.5 MG Oral Tablet; Drug: Placebo
Sponsors: Filip Krag Knop; University of Copenhagen; Juvenile Diabetes Research Foundation
Not yet recruiting
https://ift.tt/8MXpiSE
Comments
Post a Comment